Neuromyelitis Optica Spectrum Disorder in Clinical Practice
Neuromyelitis Optica Spectrum Disorder in Clinical Practice

Neuromyelitis Optica Spectrum Disorder in Clinical Practice

Doreen Ndovie

3 min
Knowledge
Play

Description

<p>Dr. Robert John Sharkus, III, DO and Richa Thakkar discuss their abstract, "FDA Approved Treatments for Neuromyelitis Optica Spectrum Disorder in Clinical Practice: A Survey of Academic Neuroimmunologists".</p> <p>You can find the abstract, along with all of our summer conference abstracts here: <a href= "https://www.aan.com/MSA/Public/Events/Details/15177">https://www.aan.com/MSA/Public/Events/Details/15177</a></p> <p><span data-sheets-value= "{"1":2,"2":"Dr. Matt Barrett talks with Dr. Philip Wade Tipton about differences in motor features of C9orf72, MAPT, and GRN variant carriers with familial frontotemporal lobar degeneration. Read the full article in Neurology. [LINK]\nThis podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information."}" data-sheets-userformat= "{"2":1063935,"3":{"1":0},"4":{"1":2,"2":14277081},"5":{"1":[{"1":2,"2":0,"5":{"1":2,"2":0}},{"1":0,"2":0,"3":3},{"1":1,"2":0,"4":1}]},"6":{"1":[{"1":2,"2":0,"5":{"1":2,"2":0}},{"1":0,"2":0,"3":3},{"1":1,"2":0,"4":1}]},"7":{"1":[{"1":2,"2":0,"5":{"1":2,"2":0}},{"1":0,"2":0,"3":3},{"1":1,"2":0,"4":1}]},"8":{"1":[{"1":2,"2":0,"5":{"1":2,"2":0}},{"1":0,"2":0,"3":3},{"1":1,"2":0,"4":1}]},"9":0,"10":1,"11":4,"12":0,"14":{"1":2,"2":0},"15":"Calibri","16":11,"23":1}" data-sheets-textstyleruns= "{"1":0}{"1":90,"2":{"6":1}}{"1":97}{"1":204,"2":{"6":1}}{"1":213}"> This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.</span></p>

Uploader

scooter_wave

scooter_wave

Neuromyelitis Optica Spectrum Disorder in Clinical Practice - Listen Free | WowFM